SCHEMBL7867925

SCHEMBL7867925

COc1ccc(C(NC(C(=O)O)n2cnc3c(O)ncnc32)(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCNB2 O95067 2/20 0.39
▸ CDK1 P06493 2/20 0.39
▸ CCNB1 P14635 2/20 0.39
▸ CCNB3 Q8WWL7 2/20 0.39
▸ KIF11 P52732 4/20 0.36
▸ HPGD P15428 2/20 0.36
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ FLT4 P35916 1/20 0.34
▸ KDR P35968 1/20 0.34
▸ ADORA3 P0DMS8 1/20 0.34
▸ EGFR P00533 1/20 0.34
▸ ERBB3 P21860 1/20 0.34
▸ HDAC1 Q13547 1/20 0.34
▸ HDAC6 Q9UBN7 1/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ ADORA2A P29274 1/20 0.34
▸ ADORA2B P29275 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7867778 0.82 CCNB2 (0.38) CCNB2CDK1CCNB1CCNB3KIF11
SCHEMBL14175360 0.70 CDK1 (0.48) CCNB2CDK1CCNB1CCNB3EGFR
SCHEMBL14175378 0.70 CCNB2 (0.46) CCNB2CDK1CCNB1CCNB3KIF11
SCHEMBL9583386 0.70 CDK1 (0.44) CCNB2CDK1CCNB1CCNB3MEN1
SCHEMBL29964989 0.69 KIF11 (0.50) KIF11MEN1KMT2AKDM4EALDH1A1
SCHEMBL29964869 0.68 KIF11 (0.47) KIF11MEN1KMT2AKDM4EALDH1A1
SCHEMBL9583072 0.68 CCNB2 (0.42) CCNB2CDK1CCNB1CCNB3HPGD
SCHEMBL2111739 0.68 TYMP (0.48) ADORA2AADORA2BTYMP
SCHEMBL7872820 0.68 HDAC1 (0.48) CCNB2CDK1CCNB1CCNB3HPGD
SCHEMBL14175383 0.68 CDK1 (0.44) CCNB2CDK1CCNB1CCNB3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6316595-B1 PNA synthesis using a base-labile amino protecting group AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2001-11-13 — — US disclosed
US-6121418-A PNA synthesis using a base-labile amino protecting group HOECHST AKTIENGESELLSCHAFT (DE) 2000-09-19 — — US disclosed
Send feedback